P53 ACTIVATES EXPRESSION OF HIC-1, A NEW CANDIDATE TUMOR-SUPPRESSOR GENE ON 17P13.3

被引:353
|
作者
WALES, MM
BIEL, MA
ELDEIRY, W
NELKIN, BD
ISSA, P
CAVENEE, WK
KUERBITZ, SJ
BAYLIN, SB
机构
[1] JOHNS HOPKINS MED INST,CTR ONCOL,BALTIMORE,MD 21231
[2] JOHNS HOPKINS MED INST,HUMAN GENET GRAD PROGRAM,BALTIMORE,MD 21231
[3] UNIV CALIF SAN DIEGO,LUDWIG CANC INST CANC RES,LA JOLLA,CA 92093
[4] UNIV CALIF SAN DIEGO,DEPT MED,LA JOLLA,CA 92093
[5] UNIV CALIF SAN DIEGO,CTR GENET MOLEC,LA JOLLA,CA 92093
[6] JOHNS HOPKINS MED INST,DEPT PEDIAT,BALTIMORE,MD 21205
[7] JOHNS HOPKINS MED INST,DEPT MED,BALTIMORE,MD 21205
关键词
D O I
10.1038/nm0695-570
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
For several human tumour types, allelic loss data suggest that one or more tumour sup presser genes reside telomeric to the p53 gene at chromosome 17p73.7. in the present study we have used a new strategy, involving molecular analysis of a DNA site hypermethylated in tumour DNA, to identify a candidate gene in this region (77p13.3). Our ap proach has led to identification of HIC-1 (hypermethylated in cancer), a new zinc-finger transcription factor gene which is ubiquitously expressed in normal tissues, but underexpressed in different tumour cells where it is hypermethylated. Multiple characteristics of this gene, including the presence of a p53 binding site in the 5'flanking region, activation of the gene by expression of a wild-type p53 gene and suppression of G418 selectability of cultured brain, breast and colon cancer cells following insertion of the gene, make HIC-1 gene a strong candidate for a tumour suppressor gene in region 17p13.3.
引用
收藏
页码:570 / 577
页数:8
相关论文
共 50 条
  • [21] Mutations of p53 tumor-suppressor gene in angiosarcoma
    Naka, N
    Tomita, Y
    Nakanishi, H
    Araki, N
    Hongyo, T
    Ochi, T
    Aozasa, K
    INTERNATIONAL JOURNAL OF CANCER, 1997, 71 (06) : 952 - 955
  • [22] THE P53 TUMOR-SUPPRESSOR GENE AND TUMOR PROGNOSIS - IS THERE A RELATIONSHIP
    DOWELL, SP
    HALL, PA
    JOURNAL OF PATHOLOGY, 1995, 177 (03): : 221 - 224
  • [23] GENE-TARGETING AND THE P53 TUMOR-SUPPRESSOR GENE
    SANDS, A
    DONEHOWER, LA
    BRADLEY, A
    MUTATION RESEARCH, 1994, 307 (02): : 557 - 572
  • [24] NEW TUMOR-SUPPRESSOR MAY RIVAL P53
    MARX, J
    SCIENCE, 1994, 264 (5157) : 344 - 345
  • [25] Evidence for another tumor suppressor gene at 17p13.3 distal to TP53 in hepatocellular carcinoma
    Guan, XY
    Sham, JST
    Tai, LS
    Fang, Y
    Li, H
    Liang, QW
    CANCER GENETICS AND CYTOGENETICS, 2003, 140 (01) : 45 - 48
  • [26] EXPRESSION OF THE P53 TUMOR-SUPPRESSOR GENE-PRODUCT IS A DETERMINANT OF CHEMOSENSITIVITY
    PETTY, RD
    CREE, IA
    SUTHERLAND, LA
    HUNTER, EM
    LANE, DP
    PREECE, PE
    ANDREOTTI, PE
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 199 (01) : 264 - 270
  • [27] IMPLICATIONS OF THE P53 TUMOR-SUPPRESSOR GENE IN CLINICAL ONCOLOGY
    CHANG, FJ
    SYRJANEN, S
    SYRJANEN, K
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (04) : 1009 - 1022
  • [28] THE P53 TUMOR-SUPPRESSOR GENE IN BREAST-CANCER
    ELLEDGE, RM
    ALLRED, DC
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 32 (01) : 39 - 47
  • [29] p53 tumor-suppressor gene: Clues to molecular carcinogenesis
    Wang, XW
    Harris, CC
    JOURNAL OF CELLULAR PHYSIOLOGY, 1997, 173 (02) : 247 - 255
  • [30] P53 AND RB TUMOR-SUPPRESSOR GENE ALTERATIONS IN RETINOBLASTOMA
    ITO, M
    MISHIMA, HK
    INAI, K
    ITO, T
    AKIYAMA, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1994, 4 (06) : 1329 - 1332